BVI Bureau Veritas SA

Bureau Veritas successfully completes the bond issuance of EUR 500 million with a maturity in November 2031

Bureau Veritas successfully completes the bond issuance of EUR 500 million with a maturity in November 2031

PRESS RELEASE

Neuilly-sur-Seine, France – November 8, 2024

Bureau Veritas successfully completes the bond issuance of EUR 500 million with a maturity in November 2031

Bureau Veritas, a world leader in testing, inspection and certification (TIC) services, announces the successful placement of a EUR 500 million bond issue maturing in November 2031 and carrying a coupon of 3.125%.

This bond issuance was largely oversubscribed (2.3 times), enabling Bureau Veritas to price with a final spread much below initial price indications. This underlines the strong investors’ confidence in Bureau Veritas business model, its LEAP | 28 strategy as well as the quality of its credit profile. This issuance would be assigned an A3 rating by Moody’s.

This new bond allows Bureau Veritas to seize attractive market conditions for general corporate purposes and refinancing of existing indebtedness (which may include some of the existing USPP).

Admission of the bonds to trading on Euronext Paris will be effective on the settlement date, which is expected to take place on November 15, 2024.

BofA Securities and Société Générale acted as Global Coordinators and Active Joint Bookrunners.

Barclays, Commerzbank, Crédit Agricole CIB, NatWest Markets and UniCredit acted as Active Joint Bookrunners.

ABOUT BUREAU VERITAS

Bureau Veritas is a world leader in inspection, certification, and laboratory testing services with a powerful purpose: to shape a world of trust by ensuring responsible progress. With a vision to be the preferred partner for customers’ excellence and sustainability, the company innovates to help them navigate change.

Created in 1828, Bureau Veritas’ 83,000 employees deliver services in 140 countries. The company’s technical experts support customers to address challenges in quality, health and safety, environmental protection, and sustainability.

Bureau Veritas is listed on Euronext Paris and belongs to the CAC 40 ESG, CAC Next 20, SBF 120 indices and is part of the CAC SBT 1.5° index. Compartment A, ISIN code FR 0006174348, stock symbol: BVI.

For more information, visit , and follow us on and .



Attachment



EN
08/11/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Bureau Veritas SA

 PRESS RELEASE

BUREAU VERITAS: Number of shares and voting rights as of February 28, ...

BUREAU VERITAS: Number of shares and voting rights as of February 28, 2026 REGULATED INFORMATION Courbevoie, France – March 6, 2026 Information on number of shares and voting rights as provided by article 223-16 of the general regulations of the French financial markets authority AMF Issuer: Bureau Veritas DateNumber of shares (1)Number of voting rights28/02/2026453,900,202Theoretical number of voting rights: 560,823,062Number of exercisable voting rights: 550,633,982  (1) including the new shares issued in Euroclear as a result of the exercise of stock options since January 1, 2026, if ...

 PRESS RELEASE

BUREAU VERITAS : Nombre d'actions et de droits de vote au 28 février 2...

BUREAU VERITAS : Nombre d'actions et de droits de vote au 28 février 2026 INFORMATION RÈGLEMENTÉE Courbevoie, France – 6 mars 2026 Information relative au nombre d’actions et de droits de vote prévue par l’article 223-16 du règlement général de l’Autorité des marchés financiers Emetteur : Bureau Veritas Date de l’arrêtéNombre d’actions en circulation (1)Nombre total de droits de vote28/02/2026453 900 202Nombre de droits de vote théoriques : 560 823 062Nombre de droits de vote exerçables : 550 633 982  (1)   y compris les actions nouvelles créées en Euroclear du fait des levées d’options ...

Delphine Brault ... (+6)
  • Delphine Brault
  • Emira Sagaama
  • Juan Ros-Padilla
  • Luis de Toledo Heras
  • Marc Lavaud
  • Nathan Mietlicki

ResearchPool Subscriptions

Get the most out of your insights

Get in touch